2002
DOI: 10.1074/jbc.m208329200
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of Glycoprotein Ib-IX-von Willebrand Factor Interaction by cAMP-dependent Protein Kinase-mediated Phosphorylation at Ser 166 of Glycoprotein Ibβ

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
86
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 71 publications
(91 citation statements)
references
References 45 publications
5
86
0
Order By: Relevance
“…Binding of VWF to EHC Cosmc +/y and EHC Cosmc −/y platelets was analyzed as previously described (42,43). To analyze platelet activation under stimulation by different concentrations of bovine thrombin, murine platelets were washed as above.…”
Section: Methodsmentioning
confidence: 99%
“…Binding of VWF to EHC Cosmc +/y and EHC Cosmc −/y platelets was analyzed as previously described (42,43). To analyze platelet activation under stimulation by different concentrations of bovine thrombin, murine platelets were washed as above.…”
Section: Methodsmentioning
confidence: 99%
“…In humans and mice, lack of or dysfunction of the GP Ib-IX complex causes Bernard-Soulier syndrome (2) and abrogates thrombus formation in mouse models of thrombosis (4,5). To date, it is not entirely understood how the GP Ib-IX/vWf interaction is regulated, but this process in GP Ib-IX complex has been reported to involve posttranslational modification (6), intracelluar phosphorylation at cytoplasmic regions (7), and ectodomain shedding by membrane-associated disintegrin and metalloproteinase (ADAM) metallopeptidase (8). In addition to these molecular modifications of the complex itself, it has been realized that spatial localization of the complex in the platelet membrane mediated by the platelet glycosphingolipidenriched membranes (GEMs) plays critical roles in the GP Ib-IX/vWf interaction.…”
mentioning
confidence: 99%
“…22,23 A phosphorylation-specific antibody against the C-terminal sequence of GPIb␣ (RYSGHpSL; pS indicates phosphoserine) was made by immunizing New Zealand White rabbits with a synthetic peptide based on this sequence (Mimotopes, Victoria, Australia) conjugated to keyhole limpet hemocyanin via an N-terminal Cys residue, using previously described methods. 9,[23][24][25][26] The anti-phospho-Ser609 GPIb␣ antibody was affinity-purified from serum using a combination of phosphorylated and unphosphorylated forms of the immunizing peptide, as described elsewhere. 9,[23][24][25][26] Anti-Akt and anti-phospho-Ser308 Akt antibodies were purchased from Cell Signaling Technology (Beverly, MA).…”
Section: Antibodiesmentioning
confidence: 99%
“…9,[23][24][25][26] The anti-phospho-Ser609 GPIb␣ antibody was affinity-purified from serum using a combination of phosphorylated and unphosphorylated forms of the immunizing peptide, as described elsewhere. 9,[23][24][25][26] Anti-Akt and anti-phospho-Ser308 Akt antibodies were purchased from Cell Signaling Technology (Beverly, MA). A mouse anti-GPIb␣ monoclonal antibody, WM23, against the extracellular domain has been reported elsewhere.…”
Section: Antibodiesmentioning
confidence: 99%